Tuesday, August 14, 2012: 8:30 AM-11:30 AM
Georgetown, Concourse Level (Washington Hilton)
Convener:
Janice Pero
8:30 AM
Bio-based adipic acid from renewable fats and oils
Stephen Picataggio, L. Dudley Eirich, Jian Yi, Michael Walbridge and Thomas Beardslee, Verdezyne, Inc., Carlsbad, CA
Stephen Picataggio, L. Dudley Eirich, Jian Yi, Michael Walbridge and Thomas Beardslee, Verdezyne, Inc., Carlsbad, CA
9:00 AM
Dissection of the genome of an Escherichia coli strain genetically engineered and metabolically evolved to overproduce succinic acid
R. Rogers Yocum1, Sudhanshu Dole1, Wei Gong1, Tammy Grabar2, Sarah Schille1, Lin Howitt1, Andrew Collard1 and Janice Pero1, (1)Molecular Biology, Myriant Corp, Woburn, MA, (2)Cellulosic Strain Developoment, Myriant Corp, Woburn, MA
R. Rogers Yocum1, Sudhanshu Dole1, Wei Gong1, Tammy Grabar2, Sarah Schille1, Lin Howitt1, Andrew Collard1 and Janice Pero1, (1)Molecular Biology, Myriant Corp, Woburn, MA, (2)Cellulosic Strain Developoment, Myriant Corp, Woburn, MA
10:00 AM
Sustainable production of industrial chemicals using microbial biocatalysts: 1,4-Butanediol
Stephen Van Dien, Genomatica, Inc., San Diego, CA
Stephen Van Dien, Genomatica, Inc., San Diego, CA
10:30 AM
Metabolic engineering to increase production of malonyl-CoA derived products
Michael Lynch, Hans Liao, Tanya Warnecke, Michael Louie, Ashley Trahan, Eileen Spindler, Faith Watson and Ron Evans, OPXBIO, Boulder, CO
Michael Lynch, Hans Liao, Tanya Warnecke, Michael Louie, Ashley Trahan, Eileen Spindler, Faith Watson and Ron Evans, OPXBIO, Boulder, CO
11:00 AM
Biochemicals development at Novozymes: technical and commercial aspects
Alan Berry, Research and Development, Novozymes, Inc., Davis, CA and Tina Fano, Business Development and Acquisitions, Novozymes, A/S, Bagsvaerd, Denmark
Alan Berry, Research and Development, Novozymes, Inc., Davis, CA and Tina Fano, Business Development and Acquisitions, Novozymes, A/S, Bagsvaerd, Denmark
See more of: Invited Oral Papers